ID   DLL1_RAT                Reviewed;         714 AA.
AC   P97677;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1997, sequence version 1.
DT   24-JUL-2024, entry version 171.
DE   RecName: Full=Delta-like protein 1;
DE   AltName: Full=Drosophila Delta homolog 1;
DE            Short=Delta1;
DE   Flags: Precursor;
GN   Name=Dll1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Disibio G., Hebshi L., Boulter J., Weinmaster G.;
RL   Submitted (DEC-1996) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   GLYCOSYLATION.
RX   PubMed=12036964; DOI=10.1074/jbc.m204445200;
RA   Panin V.M., Shao L., Lei L., Moloney D.J., Irvine K.D., Haltiwanger R.S.;
RT   "Notch ligands are substrates for protein O-fucosyltransferase-1 and
RT   Fringe.";
RL   J. Biol. Chem. 277:29945-29952(2002).
RN   [3]
RP   FUNCTION, AND INTERACTION WITH EPN1.
RX   PubMed=22658936; DOI=10.1016/j.devcel.2012.04.005;
RA   Meloty-Kapella L., Shergill B., Kuon J., Botvinick E., Weinmaster G.;
RT   "Notch ligand endocytosis generates mechanical pulling force dependent on
RT   dynamin, epsins, and actin.";
RL   Dev. Cell 22:1299-1312(2012).
RN   [4]
RP   INTERACTION WITH NOTCH1.
RX   PubMed=28089369; DOI=10.1016/j.devcel.2016.12.013;
RA   Kakuda S., Haltiwanger R.S.;
RT   "Deciphering the fringe-mediated notch code: identification of activating
RT   and inhibiting sites allowing discrimination between ligands.";
RL   Dev. Cell 40:193-201(2017).
CC   -!- FUNCTION: Transmembrane ligand protein of NOTCH1, NOTCH2 and NOTCH3
CC       receptors that binds the extracellular domain (ECD) of Notch receptor
CC       in a cis and trans fashion manner (By similarity). Following
CC       transinteraction, ligand cells produce mechanical force that depends of
CC       a clathrin-mediated endocytosis, requiring ligand ubiquitination, EPN1
CC       interaction, and actin polymerisation; these events promote Notch
CC       receptor extracellular domain (NECD) transendocytosis and triggers
CC       Notch signaling through induction of cleavage, hyperphosphorylation,
CC       and nuclear accumulation of the intracellular domain of Notch receptors
CC       (NICD) (PubMed:22658936). Is required for embryonic development and
CC       maintenance of adult stem cells in many different tissues and immune
CC       systeme; the DLL1-induced Notch signaling is mediated through an
CC       intercellular communication that regulates cell lineage, cell
CC       specification, cell patterning and morphogenesis through effects on
CC       differentiation and proliferation (By similarity). Plays a role in
CC       brain development at different level, namely by regulating neuronal
CC       differentiation of neural precursor cells via cell-cell interaction,
CC       most likely through the lateral inhibitory system in an endogenous
CC       level dependent-manner. During neocortex development, Dll1-Notch
CC       signaling transmission is mediated by dynamic interactions between
CC       intermediate neurogenic progenitors and radial glia; the cell-cell
CC       interactions are mediated via dynamic and transient elongation
CC       processes, likely to reactivate/maintain Notch activity in neighboring
CC       progenitors, and coordinate progenitor cell division and
CC       differentiation across radial and zonal boundaries. During cerebellar
CC       development, regulates Bergmann glial monolayer formation and its
CC       morphological maturation through a Notch signaling pathway. At the
CC       retina and spinal cord level, regulates neurogenesis by preventing the
CC       premature differentiation of neural progenitors and also by maintaining
CC       progenitors in spinal cord through Notch signaling pathway. Also
CC       controls neurogenesis of the neural tube in a progenitor domain-
CC       specific fashion along the dorsoventral axis. Maintains quiescence of
CC       neural stem cells and plays a role as a fate determinant that
CC       segregates asymmetrically to one daughter cell during neural stem cells
CC       mitosis, resulting in neuronal differentiation in Dll1-inheriting cell.
CC       Plays a role in immune systeme development, namely the development of
CC       all T-cells and marginal zone (MZ) B cells (By similarity). Blocks the
CC       differentiation of progenitor cells into the B-cell lineage while
CC       promoting the emergence of a population of cells with the
CC       characteristics of a T-cell/NK-cell precursor (By similarity). Also
CC       plays a role during muscle development. During early development,
CC       inhibits myoblasts differentiation from the medial dermomyotomal lip
CC       and later regulates progenitor cell differentiation. Directly modulates
CC       cell adhesion and basal lamina formation in satellite cells through
CC       Notch signaling. Maintains myogenic progenitors pool by suppressing
CC       differentiation through down-regulation of MYOD1 and is required for
CC       satellite cell homing and PAX7 expression. During craniofacial and
CC       trunk myogenesis suppresses differentiation of cranial mesoderm-derived
CC       and somite-derived muscle via MYOD1 regulation but in cranial mesoderm-
CC       derived progenitors, is neither required for satellite cell homing nor
CC       for PAX7 expression. Also plays a role during pancreatic cell
CC       development. During type B pancreatic cell development, may be involved
CC       in the initiation of proximodistal patterning in the early pancreatic
CC       epithelium. Stimulates multipotent pancreatic progenitor cells
CC       proliferation and pancreatic growth by maintaining HES1 expression and
CC       PTF1A protein levels. During fetal stages of development, is required
CC       to maintain arterial identity and the responsiveness of arterial
CC       endothelial cells for VEGFA through regulation of KDR activation and
CC       NRP1 expression. Controls sprouting angiogenesis and subsequent
CC       vertical branch formation through regulation on tip cell
CC       differentiation. Negatively regulates goblet cell differentiation in
CC       intestine and controls secretory fat commitment through lateral
CC       inhibition in small intestine. Plays a role during inner ear
CC       development; negatively regulates auditory hair cell differentiation.
CC       Plays a role during nephron development through Notch signaling
CC       pathway. Regulates growth, blood pressure and energy homeostasis (By
CC       similarity). {ECO:0000250|UniProtKB:O00548,
CC       ECO:0000250|UniProtKB:Q61483, ECO:0000269|PubMed:22658936}.
CC   -!- SUBUNIT: Homodimer. Interacts with TJP1. Interacts with MAGI1 (via PDZ
CC       domain); forms a complex with CTNNB1 and CDH2 and promotes recruitment
CC       to the adherens junction and stabilization on the cell surface.
CC       Interacts with PSEN1; undergoes a presenilin-dependent gamma-secretase
CC       cleavage that releases a Dll1-intracellular form. Interacts with MFAP5.
CC       Interacts with MIB1. Interacts with NEURL1B; leads to ubiquitination.
CC       Interacts with NEURL1 (By similarity). Interacts with SYNJ2BP; enhances
CC       DLL1 protein stability, and promotes Notch signaling in endothelial
CC       cells. Interacts with MAGI1, MAGI2, MAGI3 and MPDZ (By similarity).
CC       Interacts (via ubiquitin) with EPN1 (via IUM domain); binding with
CC       NOTCH1 attached to neighboring cell, promotes ligand ubiquitination and
CC       EPN1 interaction, leading to NECD transendocytosis and Notch signaling
CC       (PubMed:22658936). Interacts with NOTCH1 (PubMed:28089369).
CC       {ECO:0000250|UniProtKB:O00548, ECO:0000250|UniProtKB:Q61483,
CC       ECO:0000269|PubMed:22658936, ECO:0000269|PubMed:28089369}.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000250|UniProtKB:Q61483}; Single-pass type I membrane protein
CC       {ECO:0000250|UniProtKB:Q61483}. Cell junction, adherens junction
CC       {ECO:0000250|UniProtKB:Q61483}. Membrane raft
CC       {ECO:0000250|UniProtKB:Q61483}. Note=Distributed around adherens
CC       junction in the apical endfeet through interactions with MAGI1.
CC       {ECO:0000250|UniProtKB:Q61483}.
CC   -!- PTM: Ubiquitinated by MIB (MIB1 or MIB2), leading to its endocytosis
CC       and subsequent degradation (By similarity). Ubiquitinated; promotes
CC       recycling back to the plasma membrane and confers a strong affinity for
CC       NOTCH1. Mono- and multi-ubiquitinated. Multi-ubiquitination of Lys-605
CC       by MIB1 promotes both cis and trans-interaction with NOTCH1, as well as
CC       activation of Notch signaling. Ubiquitinated by NEURL1B (By
CC       similarity). {ECO:0000250|UniProtKB:P10041,
CC       ECO:0000250|UniProtKB:Q61483}.
CC   -!- PTM: Phosphorylated in a membrane association-dependent manner.
CC       Phosphorylation at Ser-688 requires the presence of Ser-685, whereas
CC       phosphorylation at Thr-630 and Ser-685 occur independently of the other
CC       sites. Phosphorylation is required for full ligand activity in vitro
CC       and affects surface presentation, ectodomain shedding, and endocytosis.
CC       {ECO:0000250|UniProtKB:Q61483}.
CC   -!- PTM: O-fucosylated. Can be elongated to a disaccharide by MFNG.
CC       {ECO:0000269|PubMed:12036964}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U78889; AAB37343.1; -; mRNA.
DR   RefSeq; NP_114452.1; NM_032063.2.
DR   AlphaFoldDB; P97677; -.
DR   SMR; P97677; -.
DR   BioGRID; 249876; 3.
DR   IntAct; P97677; 2.
DR   STRING; 10116.ENSRNOP00000073159; -.
DR   GlyCosmos; P97677; 1 site, No reported glycans.
DR   GlyGen; P97677; 1 site.
DR   iPTMnet; P97677; -.
DR   PhosphoSitePlus; P97677; -.
DR   PaxDb; 10116-ENSRNOP00000019934; -.
DR   GeneID; 84010; -.
DR   KEGG; rno:84010; -.
DR   UCSC; RGD:70949; rat.
DR   AGR; RGD:70949; -.
DR   CTD; 28514; -.
DR   RGD; 70949; Dll1.
DR   eggNOG; KOG1217; Eukaryota.
DR   InParanoid; P97677; -.
DR   OrthoDB; 5475408at2759; -.
DR   PhylomeDB; P97677; -.
DR   Reactome; R-RNO-9013507; NOTCH3 Activation and Transmission of Signal to the Nucleus.
DR   PRO; PR:P97677; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005912; C:adherens junction; ISS:UniProtKB.
DR   GO; GO:0016324; C:apical plasma membrane; ISS:UniProtKB.
DR   GO; GO:0031410; C:cytoplasmic vesicle; ISO:RGD.
DR   GO; GO:0045121; C:membrane raft; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0005112; F:Notch binding; IPI:UniProtKB.
DR   GO; GO:0048018; F:receptor ligand activity; ISO:RGD.
DR   GO; GO:0097110; F:scaffold protein binding; ISO:RGD.
DR   GO; GO:0030957; F:Tat protein binding; ISO:RGD.
DR   GO; GO:0014002; P:astrocyte development; ISS:UniProtKB.
DR   GO; GO:0009912; P:auditory receptor cell fate commitment; NAS:UniProtKB.
DR   GO; GO:0001709; P:cell fate determination; TAS:RGD.
DR   GO; GO:0007267; P:cell-cell signaling; ISO:RGD.
DR   GO; GO:0021688; P:cerebellar molecular layer formation; ISS:UniProtKB.
DR   GO; GO:0021693; P:cerebellar Purkinje cell layer structural organization; ISS:UniProtKB.
DR   GO; GO:0072583; P:clathrin-dependent endocytosis; IDA:UniProtKB.
DR   GO; GO:0007386; P:compartment pattern specification; ISO:RGD.
DR   GO; GO:0007368; P:determination of left/right symmetry; ISO:RGD.
DR   GO; GO:0097102; P:endothelial tip cell fate specification; ISS:UniProtKB.
DR   GO; GO:0097009; P:energy homeostasis; ISS:UniProtKB.
DR   GO; GO:0001947; P:heart looping; ISO:RGD.
DR   GO; GO:0002085; P:inhibition of neuroepithelial cell differentiation; ISO:RGD.
DR   GO; GO:0042491; P:inner ear auditory receptor cell differentiation; ISO:RGD.
DR   GO; GO:0048839; P:inner ear development; ISO:RGD.
DR   GO; GO:0046331; P:lateral inhibition; ISS:UniProtKB.
DR   GO; GO:0070986; P:left/right axis specification; ISO:RGD.
DR   GO; GO:0072070; P:loop of Henle development; ISO:RGD.
DR   GO; GO:0002315; P:marginal zone B cell differentiation; ISS:UniProtKB.
DR   GO; GO:0030099; P:myeloid cell differentiation; ISO:RGD.
DR   GO; GO:2000726; P:negative regulation of cardiac muscle cell differentiation; ISO:RGD.
DR   GO; GO:0045596; P:negative regulation of cell differentiation; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0045605; P:negative regulation of epidermal cell differentiation; ISS:UniProtKB.
DR   GO; GO:0030857; P:negative regulation of epithelial cell differentiation; ISS:UniProtKB.
DR   GO; GO:0034351; P:negative regulation of glial cell apoptotic process; ISS:UniProtKB.
DR   GO; GO:0045608; P:negative regulation of inner ear auditory receptor cell differentiation; ISO:RGD.
DR   GO; GO:0032693; P:negative regulation of interleukin-10 production; ISO:RGD.
DR   GO; GO:0045638; P:negative regulation of myeloid cell differentiation; ISO:RGD.
DR   GO; GO:0045662; P:negative regulation of myoblast differentiation; ISS:UniProtKB.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0045746; P:negative regulation of Notch signaling pathway; IBA:GO_Central.
DR   GO; GO:0072006; P:nephron development; ISS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; NAS:UniProtKB.
DR   GO; GO:0060563; P:neuroepithelial cell differentiation; ISO:RGD.
DR   GO; GO:0030182; P:neuron differentiation; ISO:RGD.
DR   GO; GO:0048665; P:neuron fate specification; ISS:UniProtKB.
DR   GO; GO:0097150; P:neuronal stem cell population maintenance; ISS:UniProtKB.
DR   GO; GO:0007219; P:Notch signaling pathway; ISS:UniProtKB.
DR   GO; GO:0060853; P:Notch signaling pathway involved in arterial endothelial cell fate commitment; ISS:UniProtKB.
DR   GO; GO:0035265; P:organ growth; ISS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:0045807; P:positive regulation of endocytosis; ISS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; IDA:UniProtKB.
DR   GO; GO:0048633; P:positive regulation of skeletal muscle tissue growth; ISS:UniProtKB.
DR   GO; GO:1903672; P:positive regulation of sprouting angiogenesis; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0072014; P:proximal tubule development; ISO:RGD.
DR   GO; GO:0009954; P:proximal/distal pattern formation; ISS:UniProtKB.
DR   GO; GO:0008217; P:regulation of blood pressure; ISS:UniProtKB.
DR   GO; GO:0030155; P:regulation of cell adhesion; ISO:RGD.
DR   GO; GO:0051302; P:regulation of cell division; ISS:UniProtKB.
DR   GO; GO:0040008; P:regulation of growth; ISS:UniProtKB.
DR   GO; GO:0050767; P:regulation of neurogenesis; ISS:UniProtKB.
DR   GO; GO:0048631; P:regulation of skeletal muscle tissue growth; ISS:UniProtKB.
DR   GO; GO:0014807; P:regulation of somitogenesis; ISS:UniProtKB.
DR   GO; GO:0030947; P:regulation of vascular endothelial growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:1900746; P:regulation of vascular endothelial growth factor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0060041; P:retina development in camera-type eye; ISS:UniProtKB.
DR   GO; GO:0060042; P:retina morphogenesis in camera-type eye; ISS:UniProtKB.
DR   GO; GO:0048630; P:skeletal muscle tissue growth; ISS:UniProtKB.
DR   GO; GO:0098773; P:skin epidermis development; ISS:UniProtKB.
DR   GO; GO:0001757; P:somite specification; ISO:RGD.
DR   GO; GO:0001756; P:somitogenesis; ISS:UniProtKB.
DR   GO; GO:0021510; P:spinal cord development; ISS:UniProtKB.
DR   GO; GO:0003323; P:type B pancreatic cell development; ISS:UniProtKB.
DR   CDD; cd00054; EGF_CA; 6.
DR   Gene3D; 2.10.25.140; -; 1.
DR   Gene3D; 2.60.40.3510; -; 1.
DR   Gene3D; 2.10.25.10; Laminin; 7.
DR   InterPro; IPR001774; DSL.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR   InterPro; IPR018097; EGF_Ca-bd_CS.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR011651; Notch_ligand_N.
DR   InterPro; IPR050906; Notch_signaling.
DR   PANTHER; PTHR24044:SF380; DELTA-LIKE PROTEIN 1; 1.
DR   PANTHER; PTHR24044; NOTCH LIGAND FAMILY MEMBER; 1.
DR   Pfam; PF21700; DL-JAG_EGF-like; 1.
DR   Pfam; PF01414; DSL; 1.
DR   Pfam; PF00008; EGF; 6.
DR   Pfam; PF07657; MNNL; 1.
DR   PRINTS; PR00010; EGFBLOOD.
DR   SMART; SM00051; DSL; 1.
DR   SMART; SM00181; EGF; 8.
DR   SMART; SM00179; EGF_CA; 6.
DR   SUPFAM; SSF57196; EGF/Laminin; 3.
DR   SUPFAM; SSF57184; Growth factor receptor domain; 1.
DR   PROSITE; PS00010; ASX_HYDROXYL; 3.
DR   PROSITE; PS51051; DSL; 1.
DR   PROSITE; PS00022; EGF_1; 8.
DR   PROSITE; PS01186; EGF_2; 8.
DR   PROSITE; PS50026; EGF_3; 7.
DR   PROSITE; PS01187; EGF_CA; 2.
PE   1: Evidence at protein level;
KW   Cell junction; Cell membrane; Developmental protein; Differentiation;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Isopeptide bond; Membrane;
KW   Notch signaling pathway; Phosphoprotein; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix; Ubl conjugation.
FT   SIGNAL          1..17
FT                   /evidence="ECO:0000255"
FT   CHAIN           18..714
FT                   /note="Delta-like protein 1"
FT                   /id="PRO_0000007508"
FT   TOPO_DOM        18..537
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        538..560
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        561..714
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          176..220
FT                   /note="DSL"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00377"
FT   DOMAIN          225..253
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          256..284
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          291..324
FT                   /note="EGF-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          331..362
FT                   /note="EGF-like 4; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          369..401
FT                   /note="EGF-like 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          408..439
FT                   /note="EGF-like 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          446..477
FT                   /note="EGF-like 7; calcium-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          484..515
FT                   /note="EGF-like 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   REGION          644..690
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          711..714
FT                   /note="Interaction with MAGI1"
FT                   /evidence="ECO:0000250|UniProtKB:Q61483"
FT   COMPBIAS        672..688
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         630
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61483"
FT   MOD_RES         685
FT                   /note="Phosphoserine; by PKB"
FT                   /evidence="ECO:0000250|UniProtKB:Q61483"
FT   MOD_RES         688
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61483"
FT   CARBOHYD        476
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        178..187
FT                   /evidence="ECO:0000250"
FT   DISULFID        191..203
FT                   /evidence="ECO:0000250"
FT   DISULFID        211..220
FT                   /evidence="ECO:0000250"
FT   DISULFID        225..236
FT                   /evidence="ECO:0000250"
FT   DISULFID        229..242
FT                   /evidence="ECO:0000250"
FT   DISULFID        244..253
FT                   /evidence="ECO:0000250"
FT   DISULFID        256..267
FT                   /evidence="ECO:0000250"
FT   DISULFID        262..273
FT                   /evidence="ECO:0000250"
FT   DISULFID        275..284
FT                   /evidence="ECO:0000250"
FT   DISULFID        291..303
FT                   /evidence="ECO:0000250"
FT   DISULFID        297..313
FT                   /evidence="ECO:0000250"
FT   DISULFID        315..324
FT                   /evidence="ECO:0000250"
FT   DISULFID        331..342
FT                   /evidence="ECO:0000250"
FT   DISULFID        336..351
FT                   /evidence="ECO:0000250"
FT   DISULFID        353..362
FT                   /evidence="ECO:0000250"
FT   DISULFID        369..380
FT                   /evidence="ECO:0000250"
FT   DISULFID        374..390
FT                   /evidence="ECO:0000250"
FT   DISULFID        392..401
FT                   /evidence="ECO:0000250"
FT   DISULFID        408..419
FT                   /evidence="ECO:0000250"
FT   DISULFID        413..428
FT                   /evidence="ECO:0000250"
FT   DISULFID        430..439
FT                   /evidence="ECO:0000250"
FT   DISULFID        446..457
FT                   /evidence="ECO:0000250"
FT   DISULFID        451..466
FT                   /evidence="ECO:0000250"
FT   DISULFID        468..477
FT                   /evidence="ECO:0000250"
FT   DISULFID        484..495
FT                   /evidence="ECO:0000250"
FT   DISULFID        489..504
FT                   /evidence="ECO:0000250"
FT   DISULFID        506..515
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        605
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q61483"
SQ   SEQUENCE   714 AA;  77379 MW;  4B8EE2272BAEA27E CRC64;
     MGRRSALALA VVSALLCQVW SSGVFELKLQ EFVNKKGLLG NRNCCRGGSG PPCACRTFFR
     VCLKHYQASV SPEPPCTYGS AVTAVLGVDS FSLPDGAGID PAFSNPIRFP FGFTWPGTFS
     LIIEALHTDS PDDLATENPE RLISRLTTQR HLTVGEEWSQ DLHSSGRTDL RYSYRFVCDE
     HYYGEGCSVF CRPRDDAFGH FTCGERGEKM CDPGWKGQYC TDPICLPGCD DQHGYCDKPG
     ECKCRVGWQG RYCDECIRYP GCLHGTCQQP WQCNCQEGWG GLFCNQDLNY CTHHKPCRNG
     ATCTNTGQGS YTCSCRPGYT GANCELEVDE CAPSPCRNGG SCTDLEDSYS CTCPPGFYGK
     VCELSAMTCA DGPCFNGGRC SDNPDGGYTC HCPAGFSGFN CEKKIDLCSS SPCSNGAKCV
     DLGNSYLCRC QTGFSGRYCE DNVDDCASSP CANGGTCRDS VNDFSCTCPP GYTGRNCSAP
     VSRCEHAPCH NGATCHQRGQ RYMCECAQGY GGANCQFLLP EPPPDLIVAA QGGSFPWVAV
     CAGVVLVLLL LLGCAAVVVC VRLKLQKHQP PPDPCGGETE TMNNLANCQR EKDVSVSIIG
     ATQIKNTNKK ADFHGDHGAD KSSFKARYPT VDYNLIRDLK GDEATVRDAH SKRDTKCQSQ
     GSVGEEKSTS TLRGGEVPDR KRPESVYSTS KDTKYQSVYV LSAEKDECVI ATEV
//
